Internal Medicine, Medical Oncology · Philadelphia, PA
NPI
1437111978
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
333 Cottman Ave
Philadelphia, PA, 19111
Phone (215) 728-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
315 services
Medicare patients, 2024
76
Average age 72
Drug cost, 2024
$1.2M
195 prescriptions
Company payments, 2025
$36K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martin J Edelman was code 99214 (office e&m - established), 158 times for 54 patients. In total Martin J Edelman billed 315 services in 6 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 158 | 54 | $72.10 | $11K |
| 99215 Office E&M - Established | Facility | 92 | 33 | $102.09 | $9,393 |
| 99214 Office E&M - Established | Office | 22 | 18 | $105.19 | $2,314 |
| 99213 Office E&M - Established | Facility | 20 | 12 | $53.47 | $1,069 |
By year: 2022 $29K for 318 services; 2023 $35K for 399 services; 2024 $27K for 315 services.
Medicare prescription drug claims, 2024
In 2024, the drug Martin J Edelman prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 49 prescriptions and refills. In total Martin J Edelman wrote 195 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 49 | 49 | Under 11 | $820K |
| Oxycodone Hcl Generic | 20 | 20 | Under 11 | $143 |
| Celecoxib Generic | 16 | 16 | Under 11 | $64.49 |
| Potassium Chloride Generic | 16 | 16 | Under 11 | $260 |
| Megestrol Acetate Generic | 14 | 14 | Under 11 | $406 |
| Levothyroxine Sodium Generic | 12 | 20 | Under 11 | $81.04 |
| Rozlytrek Entrectinib | 11 | 11 | Under 11 | $207K |
Brand drugs: 82 claims; generic drugs: 113 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Martin J Edelman $36K ($35K in general payments such as food, travel and fees and $1,349 for research) from 14 companies. The largest payer was Jazz Pharmaceuticals Inc. with $11K.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 12 | $11K |
| Lantheus Medical Imaging, Inc. LNTH | 7 | $9,417 |
| GlaxoSmithKline, LLC. GSK | 2 | $3,900 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $2,865 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $2,740 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $2,220 |
| Amgen Inc. AMGN | 3 | $1,647 |
| Novartis Pharma AG NVS | 5 | $1,349 |
| Catalyst Pharmaceuticals, Inc. CPRX | 2 | $1,157 |
| Daiichi Sankyo Inc. 4568.T | 2 | $43.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.